RENTON, Wash. — Providence, the massive nonprofit health system operating 51 hospitals across the Western United States, announced a significant leadership transition on Friday, July 14, 2026. The organization has tapped Amanda Chawla, a seasoned executive from Stanford Medicine, to serve as its new Chief Supply Chain Officer (CSCO).
The appointment, which follows an exhaustive national search, marks a pivotal moment for the Renton-based giant as it seeks to stabilize its finances following four consecutive years of operating losses. Chawla is set to officially assume her new responsibilities on August 24, stepping into a role that has been held on an interim basis by Allison Corry since the retirement of long-time CSCO David Walker in November.
The Strategic Shift: Bringing Expertise to a System in Flux
Amanda Chawla arrives at Providence with a formidable reputation in healthcare operations. During her tenure of over a decade at Stanford Medicine, she served as Senior Vice President and Chief Supply Chain and Post-Acute Care Officer. In that capacity, she was responsible for guiding the academic medical center through the complexities of supply chain management, digital transformation, and operational performance optimization.
Prior to her time at Stanford, Chawla served in key leadership roles at Marin General Hospital and the healthcare infrastructure firm SIPS. Her background suggests a focus on blending technological innovation with cost-containment strategies—a combination that Providence’s executive leadership team is eager to leverage as they confront mounting inflationary pressures.
"We are confident that Amanda’s deep expertise and proven track record will be instrumental in strengthening our supply chain capabilities," said Dr. Darryl Elmouchi, Chief Operating Officer at Providence. "Her ability to navigate complex clinical and operational environments will be vital as we continue to refine our processes and ensure our caregivers have the resources they need to provide exceptional patient care."
Chronology of Leadership and Financial Headwinds
The search for a permanent CSCO comes at a time of extreme volatility for the Providence system. The path to this appointment has been marked by a series of high-level transitions and intense financial scrutiny:
- November 2025: Long-time Chief Supply Chain Officer David Walker retires, necessitating a transition in leadership.
- Late 2025 – Mid 2026: Allison Corry steps in as interim CSCO, managing the department during a period of rising supply costs and logistical hurdles.
- Early 2026: Providence continues its comprehensive effort to exit its health insurance business, signaling a strategic retreat to focus on its core hospital operations.
- July 14, 2026: Providence formally announces the appointment of Amanda Chawla following a national recruitment process.
- August 24, 2026: Official start date for Chawla at the Providence headquarters.
This timeline reflects a system in the midst of a broader "reset." After four years without an annual profit, Providence’s leadership has been forced to take drastic measures. These include restructuring the executive team, implementing nonclinical hiring freezes, and executing targeted layoffs to reduce the overhead that has plagued the system’s bottom line.
Supporting Data: The Cost of Care in an Inflationary Era
The urgency behind Chawla’s hire is clearly visible in the system’s recent financial disclosures. Despite aggressive cost-mitigation strategies, Providence has faced severe economic headwinds, including supply chain volatility, labor shortages, and inflationary pressures that have pushed the cost of medical goods to record highs.
According to the system’s 2025 annual financial results, Providence’s total supply expenses ballooned to $5.3 billion, up significantly from $4.9 billion in 2024. This 9% year-over-year increase was primarily driven by two critical areas:
- Pharmaceuticals: Spending on drugs rose by 11% in a single year.
- Medical Supplies: Basic clinical equipment and consumables saw a 9% increase in costs.
These figures underscore the massive challenge facing the incoming CSCO. However, there are glimmers of progress. Through rigorous cost-containment efforts—likely a precursor to the initiatives Chawla will oversee—Providence managed to reduce its operating loss from $363 million in 2024 to $132 million in 2025. While the system remains in the red, the narrowing of the gap provides a baseline of hope that current strategic adjustments are beginning to yield results.
Official Responses and Strategic Outlook
Providence’s executive team has maintained that the path to profitability requires a multifaceted approach. By hiring an executive with Chawla’s specific experience in "digital innovation" and "operational performance," the organization is signaling that it no longer views the supply chain as a back-office function, but as a strategic lever for financial survival.
In a statement released alongside the appointment, the organization emphasized that Chawla’s role will extend beyond simple procurement. She will be tasked with modernizing the supply chain to prevent the kind of "spend leakage" that contributed to the $5.3 billion expenditure in 2025.
Industry analysts suggest that the hire aligns with the broader trends in the nonprofit health sector, where systems are increasingly moving away from decentralized purchasing and toward highly automated, data-driven supply networks. By leveraging her experience from the high-tech, high-acuity environment of Stanford Medicine, Providence is hoping to gain better visibility into its spending habits and inventory management.
Implications for the Future of Providence
The appointment of Chawla is not an isolated event; it is part of a larger, systemic restructuring designed to save the organization from long-term financial insolvency. The implications of this transition are far-reaching:
1. Operational Efficiency as a Priority
The "hustle" to shore up financial footing has included a move toward increasing the volume of lucrative, high-margin services, such as elective surgeries. A more efficient supply chain is critical to this goal; delays in surgical kits or equipment shortages can result in cancelled procedures and lost revenue. Chawla will be expected to ensure that the supply chain supports these growth areas with zero friction.
2. A Slimmer, More Focused Organization
The decision to exit the insurance business by 2027 is a major strategic pivot. By shedding the administrative and financial burdens of the insurance arm, Providence is attempting to focus its capital and human resources back onto the bedside. Chawla’s expertise in "post-acute care" during her Stanford tenure will likely be leveraged as Providence integrates its supply chain more tightly with its outpatient and post-acute services, ensuring continuity of care that is both cost-effective and clinically sound.
3. The Human Impact
While the news of a new executive hire is positive, the backdrop of recent layoffs and hiring freezes remains a point of tension for the workforce. The success of Chawla’s tenure will be measured not just in balance sheets, but in her ability to maintain morale within a supply chain department that has been under intense pressure for several years.
4. Navigating Macro-Economic Forces
The 9% increase in supply costs is not entirely within the control of a single hospital system. Tariffs, global supply chain bottlenecks, and the rising cost of raw materials for medical devices are global issues. Chawla’s role will require her to be a savvy negotiator with vendors and to potentially explore new, more resilient procurement partnerships that can insulate Providence from future shocks.
Conclusion
As Amanda Chawla prepares to join Providence, the eyes of the healthcare industry remain fixed on the system. For a major nonprofit to go four years without a profit is an unsustainable trajectory. The appointment of a high-caliber executive from a top-tier institution like Stanford Medicine indicates that Providence is serious about systemic reform.
The challenge ahead is immense: Chawla must balance the need for immediate cost-cutting with the imperative to maintain clinical excellence. If she can successfully modernize the supply chain and help the organization regain its financial footing, her tenure will likely be remembered as the turning point for one of the West Coast’s most critical healthcare providers. For now, the integration of new leadership, combined with a leaner corporate structure and a narrowing operating loss, provides a tentative roadmap for a system attempting to navigate its way back to financial health.
